Clinical trials
Completed Observational Asperger Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| Boston Children's Hospital | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Hoffmann-La Roche | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| Rutgers University | 1 |
| Social Insurance Institution, Finland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asperger Syndrome | 13 |
| Autism Spectrum Disorder | 8 |
| Autistic Disorder | 8 |
| Child Development Disorders, Pervasive | 5 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| Intellectual Disability | 2 |
| Learning Disabilities | 2 |
| Rett Syndrome | 2 |
| Alzheimer Disease | 1 |
| Child Behavior Disorders | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.